Analysis of Single Use Assemblies Market Covering 30+ Countries Including Analysis of US, Canada, UK, Germany, France, Nordics, GCC countries, Japan, Korea and many more
Worldwide demand for single use assemblies is predicted to skyrocket at a CAGR of 24% from 2022 to 2032. Currently, the global single-use assemblies market is valued at US$ 3 billion and is expected to climb to US$ 25.8 billion by 2032-end.
Global sales of bag assemblies are anticipated to increase at an astounding CAGR of 29% from 2022 to 2032. Bag assemblies are becoming more popular due to their benefits such as cheaper maintenance expenses, less capital expenditure, lower cost of shipping due to low weight, and no need for validation or cleaning.
Bag assemblies are further subdivided into 2D and 3D bag assemblies. Due to variables such as technological developments, 2D bag assemblies hold the highest market share.
Single use assemblies are classified into bag assemblies, filtration assemblies, bottle assemblies, mixing system assemblies, and others.
Demand for filtration assemblies is expected to expand at a CAGR of 24% during the forecast period. The use of filtration assemblies for bulk and final-fill processes has been encouraged by improved regulatory prospects and the requirement to reduce the danger of contamination.
Since single-use filtration assemblies eliminate away with sterilizing steps and the associated validation procedures, they offer a versatile and effective replacement for stainless-steel systems.
Single-use assemblies are plastic fluid paths that are self-contained, preassembled, and built from a variety of standard components. They are often gamma-irradiated for sterility and are ready to use.
To match particular applications and unit activities, single use assemblies might be modified. The execution of many procedures in manufacturing and R&D activities depends heavily on single use assemblies.
A transfer between single-use and hybrid systems, as well as between cleanroom or isolator walls, depends on tubing assemblies.
Sample bottles, filters, tubing, clamps, check valves, fittings, sterile connectors, and seals are among the industrial products that are frequently utilised. During the projection period, the single use assemblies market’s growth is anticipated to be aided by the expanding biologics sector, ongoing bioprocessing technological advancements, rising biopharmaceutical R&D, and increasing acceptance of single use assemblies by various CMOs.
In addition to reducing costs, single-use technologies also cut down on sterile connections, integrity testing, and tubing time by up to 90%. Due to their readiness for usage, unlike traditional filtration systems, single-use flirting systems also reduce process time. Multiple production facilities will be needed to satisfy the growing market demand for biopharmaceuticals for them to be commercially successful.
The significance of single-use technology in advancing cutting-edge research into these ailments, such as cancer research and medicines for uncommon diseases, is expected to increase, spurring single use assembly demand.
Thus, global sales of single use assemblies are likely to surge in the years ahead due to the rising fear of contagious infections and the increasing rate of chronic diseases.
Single Use Assemblies Market Size (2022E)
US$ 3 Billion
Forecasted Market Value (2032F)
US$ 25.8 Billion
Global Market Growth Rate (2022-2032)
China Market Growth Rate (2022-2032)
Key Companies Profiled
Know thy Competitors
Competitive landscape highlights only certain players
Complete list available upon request
“COVID-19 Generated New Opportunities for Manufacturers of Single Use Assemblies”
As a result of COVID-19, demand for single-use assemblies has increased even more because the technology behind them makes it possible to manufacture medicines and vaccines more quickly, with more accuracy and efficiency.
The unique single-use bags were perfect for cold chain storage and collection since they had low leachable and extractable levels and a wide range of operating temperatures.
“Ongoing Developments in HIV Vaccines & Rising Cases of Cancer”
The development of effective innovative biologics solutions for the detection and treatment of cancer is expanding due to the increasing incidences of infectious diseases and cancer.
Furthermore, the business is expected to expand as a result of an increase in contagious diseases, such as lower respiratory infections and the Human Immunodeficiency Virus (HIV), in recent years as a result of climate change, shifting lifestyle patterns, and fast urbanization.
“Rising Incidence of Contagious Infections across the World”
Improved diagnostic and therapeutic options, such as biologics, are needed for the treatment of infectious diseases, which are projected to accelerate demand for single-use assemblies. Novel vaccine advancements for several infectious illnesses are also anticipated to support sales growth.
These initiatives highlight the utilization of recently developed technologies in the biologics industry, and this vaccine aims to produce antibodies that can neutralize HIV particles. Similar cooperative efforts are being made to create new vaccine alternatives as a result of emerging infectious diseases that have the potential to become pandemics in the future.
The implementation of single use assemblies for the manufacturing of newly designed vaccines will therefore likely be strongly influenced by such technological advancements and cooperative initiatives in the coming years.
Furthermore, the usage of single use assemblies boosts productivity in the production process by reducing automation complexity and eliminating the need for transition validation or cleaning in between operations.
More Insights, Lesser Cost (-50% off)
Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR
“Risks Related to Cross-contamination”
A majority of end users, including big research centres and pharmaceutical firms, need a lot of single use assemblies to run several production processes and research investigations. High temperature and ambient conditions are used for these experiments and processes.
Single use assemblies are composed of plastics and polymers that contain different preservatives that are likely to deteriorate in small amounts as extractables and leachables. This raises the possibility of material cross-contamination. Therefore, the sales of single-use assemblies are being constrained by substantial concerns about extractables and leachables.
“Rising Cases of Cancer & High Investments in Drug Discovery Research Boost Sales of Single Use Assemblies in North America”
North America dominates the worldwide sales of single-use assemblies. The region's large market share can be attributed to several factors, including its well-established biopharmaceutical industry, the wide availability of single use assemblies provided by local industry leaders, the rising production of biologics and biosimilars, the rising cases of diseases such as cancer, and investments and financing in drug discovery research.
Single use assemblies have been increasingly popular over the past ten years due to their benefits. Many pharmaceutical and biopharmaceutical companies anticipate expanding their single-use manufacturing facilities in emerging nations such as China, India, and South Korea to turn these nations into a hub for outsourcing bioprocesses.
These nations also offer favourable regulatory environments and cost advantages. The growing amount of investments made by major market participants in developing nations also supports this growth.
Japan, South Korea, and Southeast Asian Countries are noteworthy markets in the Asia Pacific region.
“Well-established Pharma Sector Driving Need for Demand for Single Use Assemblies”
According to the International Trade Administration (ITA), which is run by the U.S. Department of Commerce to encourage and support foreign investment in the country, the United States is the largest biopharmaceutical market in the world, accounting for almost a third of global sales, and it leads the world in biopharmaceutical research and development.
One of the best domestic settings across the globe for pharmaceutical research and commercialization, with low market barriers, is the United States. The sophisticated pharmaceutical and biopharmaceutical industries, as well as a favourable domestic climate, encourage sales of single use assemblies.
“Growing Biological Industry Supporting Sales of Single Use Assemblies”
Germany is expected to dominate the Europe single use assemblies market during the forecast period. The single use assemblies market in this country is considered to be influenced more by biological than by pharmaceutical therapeutic options.
As a result, the demand for the German biopharmaceutical contract manufacturing market is rising, which in turn boosts sales of single use assemblies. More research and clinical trials in biopharmaceuticals are being conducted to cut costs and focus on outsourcing the majority of research activities.
“Rising R&D Activities in Biopharmaceutical & Pharmaceutical Manufacturing Units”
Demand for single use assemblies is currently dominated by the biopharmaceutical and pharmaceutical industries, which also account for the largest portion of revenue-more than 40%.
To simplify the upstream procedure, biopharmaceutical and pharmaceutical companies constantly use single use assemblies and consumables such as single-use manifolds, aseptic bottle transfers, and bespoke tube kits.
Pharmaceutical and biopharmaceutical companies have greatly increased the number of funds they spend on research and development. Thus, the demand for single-use assemblies is driven by the growth of biopharmaceutical manufacturing facilities.
In recent years, a large number of medications have been approved and are now categorised as "specialty pharmaceuticals”. The use of specialty medications, which may require particular patient management or monitoring, is reserved for the treatment of chronic, complex, or unusual disorders.
Biologics (big-molecule drugs based on living cell lines) make up a substantial portion of specialised medications; are pricy, difficult to replicate, and expensive to produce. Thus, the development of affordable biologics has become more important to biopharmaceutical businesses.
Don't Need a Global Report?
Save 40% on Country & Region specific reports
Numerous significant participants exist in the highly fragmented single use assemblies industry. Key players in the single use assemblies market are Sartorius AG, Danaher Corporation, Thermo Fisher Scientific, GE Healthcare, Parker Hannifin Corporation, Merck KGaA, Avantor Inc, and Saint-Gobain.
- Premium Report Details -
- Let's Connect -
- Quick Contact -
- Get Started -
Get insights that lead to new growth opportunitiesBuy Now
Get A Special pricing for start-ups and universitiesEnquiry Before Buying
- Humble, Yet Honored -
- Related Reports -
Demand for single use assemblies is predicted to expand at a CAGR of 24% from 2022 to 2032.
The market for single use assemblies is predicted to reach US$ 25.8 billion by 2032.
Currently, worldwide sales of single use assemblies are valued at US$ 3 billion.
China’s single use assemblies market is predicted to rise at a significant CAGR of 30.5% during the forecast period.
Key suppliers of single use assemblies are Sartorius AG, Danaher Corporation, Thermo Fisher Scientific, GE Healthcare, Parker Hannifin Corporation, Merck KGaA, Avantor Inc, and Saint-Gobain.
Need An Exclusive Report For Your Unique Requirement?